Baidu
map

必看!2016年糖尿病相关研究亮点精华汇总

2016-12-14 MedSci MedSci原创

时光荏苒,岁月如梭,锦年素时,稍纵即逝,又是到年终盘点的时刻!相比于去年,2016年糖尿病取得了重大的研究成果,不论从基础还是临床研究,从不同方向、不同角度对糖尿病及其并发症的临床诊治进行了深入研究,为糖尿病的临床管理寻找最新方向。本文梅斯医学编辑就2016年糖尿病相关研究亮点进行汇总。【1】BMC Biotechnology:糖尿病福音,转基因蛆虫治疗足溃疡!北卡罗来纳州大学的研究人员发现,

时光荏苒,岁月如梭,锦年素时,稍纵即逝,又是到年终盘点的时刻!相比于去年,2016年糖尿病取得了重大的研究成果,不论从基础还是临床研究,从不同方向、不同角度对糖尿病及其并发症的临床诊治进行了深入研究,为糖尿病的临床管理寻找最新方向。本文梅斯医学编辑就2016年糖尿病相关研究亮点进行汇总。

【1】BMC Biotechnology:糖尿病福音,转基因蛆虫治疗足溃疡!

北卡罗来纳州大学的研究人员发现,转基因绿蝇(丝光绿蝇)幼虫可以产生和分泌人类生长因子,有助于促进细胞生长和伤口愈合。

将无菌实验室养的绿蝇幼虫用于蛆虫清创治疗(MDT),主要是不愈合的伤口,尤其是糖尿病足溃疡,可以促进其愈合。使用蛆清洁创面,不仅可以去除坏死组织,还能够分泌抗微生物因子。这是符合成本效益的治疗,并且已经得到了食品和药物管理局(FDA)的批准。然而,关于MDT缩短创面愈合时间的随机临床试验证据还缺乏。

北卡罗来纳州研究人员通过基因工程创造出能分泌人血小板衍生生长因子(PDGF)的蝇蛆,该物质能刺激细胞生长,促进伤口愈合。

北卡罗来纳州的昆虫学教授Max Scott和来自北卡罗来纳州和新西兰梅西大学的同事通过两种不同的技术让绿蝇幼虫分泌PDGF-BB。

一种是利用热引发转基因绿蝇幼虫分泌PDGF-BB。当幼虫处于高温时(37摄氏度),可在其特定结构里检测到人类生长因子,但是幼虫的分泌物中没有PDGF-BB,使得其没有临床使用意义。

接着Scott和同事设计出了第二种方法。给只产生PDGF-BB的绿蝇幼虫喂食缺乏抗生素四环素的饮食,结果发现幼虫排泄物和分泌物中PDGF-BB含量很高,因此也具有潜在的临床应用价值。

Scott说:“绝大多数糖尿病患者居住在低收入或中收入国家,昂贵的治疗费用像大山一样压着他们。而我们的试验从原理上证明了,未来使用能产生多种生长因子的转基因L.蝇株幼虫治疗糖尿病足溃疡是可行的,可以减少患者的截至和其他糖尿病相关风险,并且符合成本效益。”(文章详见--BMC Biotechnology:糖尿病福音,转基因蛆虫治疗足溃疡!

【2】Diabetes care:周末放肆睡,或可降低糖尿病风险

最近一项在芝加哥大学睡眠实验室进行的短期研究显示,几个小时的闭眼休息是一种更为放松的治疗,对任何可能处于糖尿病边缘的人都有重要的意义。

CDC美国现有2910万糖尿病患者,发生率接近1/10。如此规模巨大的医疗问题需要深入到各个层面的研究。糖尿病是十分复杂的疾病,应对其潜在途径进行深入探究以遏制疾病的发展。而本研究是从睡眠角度探究其对糖尿病的影响。

睡眠可能不足饮食和运动一样对糖尿病的影响巨大,不过先前有荟萃分析表明,7-8小时睡眠时间的人群患2型糖尿病风险最低,而除此之外不管睡眠时间长短,均会显著增加2型糖尿病风险。还有研究表明,睡眠不足的糖尿病患者早上23%的血糖过高,48%的患者胰岛素水平过高。换句话说,睡眠不足的糖尿病患者与合适睡眠量的患者相比,胰岛素抵抗的可能性高出80%。以上研究结果似乎都在表明一点,睡眠不足不仅会加剧现有糖尿病病情,还会增加健康人群糖尿病风险。

研究结果表明,年轻健康的年轻人如果能在周末放肆睡觉,弥补工作日的睡眠不足,仍可以降低睡眠不足导致的糖尿病风险。不过研究者也意识到该研究只是针对小样本的短期研究,不足以得出有力的结论,并且长期睡眠不足的人群更容易进食高脂肪高糖的食物。因此研究者计划在以后进行饮食控制的更大样本更长周期的研究。(文章详见--Diabetes care:周末放肆睡,或可降低糖尿病风险

【3】Am J Epidemiol:上海交大宁光院士发表糖尿病研究新成果

来自上海交通大学宁光院士及其团队在Am J Epidemiol杂志上发表糖尿病最新研究成果。研究研究表明,配偶之间共享一些相同的生活方式。研究结果发布在8月16日的American Journal of EPIDEMIOLOGY杂志上。 

本研究以社区为基础,2011-2012年间年龄为40岁或以上的中国成人群体中,调查了糖尿病患者的配偶是否具有更高的糖尿病和心血管代谢疾病发病率。

在这项研究中,研究人员共纳入34,805对夫妻。所有参与者均接受了标准口服葡萄糖耐量试验,并提供了详细的临床、社会人口及生活方式信息。他们根据标准来定义了糖尿病和多种心血管代谢疾病。相比于配偶为非糖尿病患者的参与者,配偶罹患糖尿病的参与者具有较高的机率罹患糖尿病、肥胖、代谢综合征和心血管疾病。且这种关联独立于年龄、身高体重指数、教育、糖尿病家族史、吸烟、饮酒、身体活动和饮食。

研究结果,配偶罹患糖尿病为鉴别处于糖尿病和心血管代谢疾病风险中的个体提供了一个简单、有价值的信息。(文章详见--Am J Epidemiol:上海交大宁光院士发表糖尿病研究新成果

【4】Diabetes Care:人类胰岛移植完成III期临床 根治1型糖尿病已见曙光!

最新临床试验结果表明进行胰岛移植能够帮助1型糖尿病患者预防低血糖症,低血糖会导致病人出现痉挛,意识丧失,严重者甚至发生死亡,对生命造成威胁。研究人员发现这种治疗对于遭受过严重低血糖症的病人非常有效。
 
这项III期临床试验由美国国立卫生研究院NIAID和NIDDK两个研究所共同资助,同时该试验的设计也得到了美国FDA的认可,从一定程度上为纯化人类胰岛细胞的商品化应用提供了保证。相关结果在线发表在国际学术期刊Diabetes Care上。

这项研究共包含48名参与者,这些参与者都存在低血糖症意识损伤,同时也经历过严重的低血糖症。研究人员通过标准化流程从已故的人类供体身上获得了纯化的胰岛细胞,通过门静脉注射对参与者进行了胰岛移植,所有研究参与者都至少接受过一次胰岛移植。接受移植的患者们需要终生服用免疫抑制药物,防止免疫系统排斥移植细胞。
 
首次移植一年之后,88%的参与者没有再发生过严重的低血糖症,他们体内建立了近乎正常的血糖水平,并且恢复了低血糖症意识。两年之后,71%的参与者仍然能够达到移植成功的标准。
 
研究人员表示,只需要很少数量具备胰岛素合成分泌功能的胰岛细胞就能够帮助恢复低血糖症意识,但是有些人还需要使用胰岛素帮助完全控制血糖水平,这些人适合再次接受胰岛细胞移植。参与者中有25人接受了第二次胰岛细胞移植,1人接受了第三次胰岛细胞移植,一年之后,52%的参与者不再需要胰岛素治疗。(文章详见--Diabetes Care:人类胰岛移植完成III期临床 根治1型糖尿病已见曙光!

【5】JAMA:1988-2014年间美国成人糖尿病患者肾病的变化

糖尿病肾病是导致美国及世界上慢性和终末期肾脏疾病的首要原因。人口统计学和治疗的变化可能会影响糖尿病肾病的患病率和临床表现。本研究旨在分析美国成人糖尿病患者的肾病的临床表现。

采用横断面研究探究1988年至2014年间参与国家健康和营养检查调查的20岁或以上的糖尿病患者。糖尿病定义为糖化血红蛋白大于6.5%或使用降血糖药物。

结果共纳入了6251名成人糖尿病患者(1988-1994年1431名,1999-2004年1443名,2005-2008年1280名,2009-2014年2097名)。糖尿病肾病定义为持续性蛋白尿,eGFR持续减少,或两者兼有。糖尿病肾病的患病率从1988-1994年的28.4%降至2009-2014年的26.2%,并未发生明显的改变。然而,白蛋白尿的患病率从1988-1994年的20.8%降到2009-2014年的15.9%。相反,eGFR降低的发生率从1988-1994年的9.2%提高到2009-2014年的14.1%,与eGFR严重降低的模式类似。在年龄和种族/族裔上,蛋白尿的时间趋势存在明显的异质性,仅在年龄小于65岁的成人及非西班牙裔白人可发现蛋白尿的患病率降低,而年龄或种族/族裔上,GFR降低的发生率增加无显著差异。2009-2014年,约820万糖尿病患者出现蛋白尿、eGFR降低,或两者兼有。

总而言之,该研究发现1988-2014年的糖尿病成人患者中,糖尿病肾脏病的总患病率没有明显变化,而白蛋白尿的患病率下降、eGFR降低的患病率增加。(文章详见--JAMA:1988-2014年间美国成人糖尿病患者肾病的变化

【6】Lancet子刊:不是伪科学!身高确实影响糖尿病及癌症风险

一项刊登于国际杂志The Lancet Diabetes & Endocrinology上的研究论文中,来自德国糖尿病研究中心等机构的研究人员通过研究描述了全世界个体升高增加和患慢性非传染性疾病之间的关联;研究人员发现,高个儿人患心血管疾病和2型糖尿病的风险较低,但患癌风险却很高,同时研究者还讨论了饮食因素和其它机制试图来解释上述关联性发生的原因。

在不同的生长阶段机体身高的增加是机体动物蛋白富集及营养过剩的主要标志,在母体子宫内胎儿机体一生的程序可能都会建立,直到开始建立产生胰岛素样的生长因子1和2以及IGF-1/2系统;在机体其它的影响中,系统的激活就会引发机体对胰岛素活性更加敏感,随后正向影响脂质的代谢。而本文最新研究结果显示,高个儿人群更容易对胰岛素敏感,而且肝脏中脂肪含量水平较低,这或许就可以帮助解释其患2型糖尿病和心血管疾病风险降低的原因,研究者认为,高个子人群机体中存在特殊保护机制可以抵御脂质代谢障碍的发生,然而IGF-1/2系统及其它信号通路的激活或许和特性癌症发生风险增加直接相关,尤其是乳腺癌结肠癌以及黑色素瘤,研究者推测这可能是细胞生长不断被激活所导致的,而最终则会导致心血管疾病风险和2型糖尿病发病风险的反向相关,但和癌症却是正向相关的。

最后研究者呼吁将机体生长和身高因素纳入到抑制上述非传染性慢性疾病的预防之中,研究者们非常清楚尽管高个子人群受心血管疾病和2型糖尿病的影响较少,但却患癌风险增加;更为重要的是,饮食的重要性也不可忽略,尤其是在个体怀孕期间以及个体儿童和青春期等阶段。(文章详见--Lancet子刊:不是伪科学!身高确实影响糖尿病及癌症风险

【7】重大突破!科学家终于解开1型糖尿病医学谜题

在最近发表于《Diabetes》期刊的研究中,英国研究人员识别出一种1型糖尿病患者中之前未知的遭受免疫系统攻击的分子,解决了一项几十年的医学谜题。

这项开创性的研究由英国林肯大学(University of Lincoln)Michael Christie博士领导,可能更好地识别面临1型糖尿病风险的人群,并为开发防止该病发生发展的新疗法提供信息。

在1型糖尿病中,免疫系统会对通常被忽视的自身抗原(autoantigens)做出反应。1型糖尿病患者的血液中存在特定针对每种自身抗原分子的抗体。目前已经拥有检测这些抗体的测试:检测到的抗体越多,个体罹患1型糖尿病的风险越高。这些测试目前被用于识别那些1型糖尿病风险最高的人群,并可能在未来提供干预和阻止疾病发展的机会。

迄今为止,科学家们已经发现了4种在1型糖尿病中被免疫系统攻击的分子。但在过去20年里,第5种被称为"Glima"的分子的身份一直是个谜。在新的研究中,Christie博士的团队成功识别出第5种分子是Tetraspanin-7,这可能使预测1型糖尿病的测试更为准确。他们正在寻找方法以阻断免疫攻击,从而防止这些高风险人群罹患1型糖尿病。(文章详见--重大突破!科学家终于解开1型糖尿病医学谜题

【8】ENDO 2016:甲状腺功能减退可能增加糖尿病风险

这项基于人群的前瞻性队列研究,Chaker和同事对8452名≥45岁的成年人进行了一样研究,参与者平均年龄65岁,研究人员获取了甲功和血糖等数据,平均随访7.9年。

随访期间有1100名参与者发展为前驱糖尿病,798名发展为糖尿病。校正基线年龄、性别、HDL胆固醇、血压和血糖等因素后,更高的促甲状腺激素(TSH)与更高的糖尿病风险相关(HR = 1.13; 95% CI, 1.08-1.18, per logTSH),更高的游离甲状腺素水平与更低的糖尿病风险相关(HR = 0.96, CI, 0.93-0.99, per pmol/L)。就算在正常范围内,这种联系也存在(TSH, HR = 1.24; 95% CI, 1.06-1.45; 游离 T4, HR = 0.96; 95% CI, 0.93-0.99, per pmol/L)。正常范围内甲功最高值组与最低值组相比,前驱糖尿病进展为糖尿病的风险为1.4倍(P = .002)。

Chaker说:“我们的结果表明,甲状腺激素在2型糖尿病的病理发展机制中有一定作用。不过我们还需要进一步了解和认识甲状腺激素与糖尿病的关系。”(文章详见--ENDO 2016:甲状腺功能减退可能增加糖尿病风险

【9】PLoS Med:骑自行车远离糖尿病

无论是休闲娱乐还是上班出行,自行车都是很好的选择。本研究的目的是:探究娱乐和通勤自行车、骑车习惯的改变和2型糖尿病(T2D)风险的关系。

从基线的1993到1997年,纳入了来自丹麦的24623名男性和27890名女性,年龄50-65岁,没有T2D和其他慢性疾病,进行一系列的评估,包括生活方式问卷调查和自行车习惯。大约5年后,进行第二次评估,参与者完成了一份新的、最新的生活方式问卷。

结论:无论是休闲娱乐还是上班出行,自行车都是很好的选择,都可以降低糖尿病风险。不管是一直骑自行车还是生命晚期才开始,均可以降低糖尿病风险。(文章详见--PLoS Med:骑自行车远离糖尿病

【10】Diabetes Care:1型糖尿病患者低血糖和心血管事件、死亡风险研究

根据一项以人群为基础的队列研究的数据,在过去一年中发生严重低血糖事件的1型糖尿病患者,死亡或心血管疾病的风险增加。

来自台湾成功大学医学院的Chin-Li Lu博士进行了两项巢式病例对照研究,纳入10411名1型糖尿病患者,探究低血糖对全因死亡率和心血管疾病风险的影响。数据包括了564个死亡者和匹配的1615例对照组。当然还有发生主要心血管事件(n = 743)和没有发生这些事件的对照组(n = 1439)。

数据显示,在过去的一年里有严重低血糖事件的患者,死亡几率增加了2.74倍(95% CI, 1.96-3.85);出现心血管事件的可能性增加了2.02倍(95% CI, 1.35-3.01)。在过去1至3年或3到5年发生低血糖事件也与更高的全因死亡率有关 (OR = 1.94; 95% CI, 1.39-2.71和OR = 1.68; 95% CI, 1.15-2.44)。

在那些死亡的患者中,研究人员确定了三个主要原因:44.8%死于糖尿病,16.4%死于恶性肿瘤,12.4%死于循环系统疾病。死者也倾向于更多的生活在农村地区,并有更低的收入为基础的保险费。

研究人员写道:“患者和临床工作者应适当管理1型糖尿病,防止严重低血糖的发生。如果发生了低血糖事件,应该告诉患者接下来的全因死亡率或心血管事件的可能风险。”(文章详见--Diabetes Care:1型糖尿病患者低血糖和心血管事件、死亡风险研究

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1800436, encodeId=fc6c180043690, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Jun 14 22:11:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171533, encodeId=b9ca1e153371, content=获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0HwU7ogMvvRprWicAKSvxWXjwtmeo8SyGdWKEInVUiad7A5yiaAiaBue3SiaFNp57wAibKBCcvXrof9ZUV8fgV2jyNtw/0, createdBy=a2b42012587, createdName=wangjian123, createdTime=Fri Jan 20 09:41:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164661, encodeId=119116466127, content=感想,敢做,才能成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuIJQYq83p8jw8cQBJm4ya1HUMWB7ooS7HMvcNpiarQlbkDejrUObqFvEW3xb4xJvrfyVw0WR4ibBdh/0, createdBy=32fd1961793, createdName=399, createdTime=Wed Dec 21 16:09:45 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163994, encodeId=31f4163994e5, content=再次学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Dec 19 07:42:49 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163903, encodeId=3de316390347, content=高大上的研究啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161111/IMG5825E270980429526.jpg, createdBy=f49f1974260, createdName=我是林下之夕, createdTime=Sun Dec 18 22:32:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163011, encodeId=549f163011d7, content=字习了学习再次学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 11:22:42 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162973, encodeId=74f81629e30d, content=跟进新进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Thu Dec 15 08:59:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162966, encodeId=b97c16296659, content=不错学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 08:50:26 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162954, encodeId=82dc1629545a, content=思路很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19061994286, createdName=1e1b1150m51(暂无匿称), createdTime=Thu Dec 15 08:18:31 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162864, encodeId=abe816286406, content=挺好的,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Wed Dec 14 23:08:37 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1800436, encodeId=fc6c180043690, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Jun 14 22:11:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171533, encodeId=b9ca1e153371, content=获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0HwU7ogMvvRprWicAKSvxWXjwtmeo8SyGdWKEInVUiad7A5yiaAiaBue3SiaFNp57wAibKBCcvXrof9ZUV8fgV2jyNtw/0, createdBy=a2b42012587, createdName=wangjian123, createdTime=Fri Jan 20 09:41:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164661, encodeId=119116466127, content=感想,敢做,才能成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuIJQYq83p8jw8cQBJm4ya1HUMWB7ooS7HMvcNpiarQlbkDejrUObqFvEW3xb4xJvrfyVw0WR4ibBdh/0, createdBy=32fd1961793, createdName=399, createdTime=Wed Dec 21 16:09:45 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163994, encodeId=31f4163994e5, content=再次学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Dec 19 07:42:49 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163903, encodeId=3de316390347, content=高大上的研究啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161111/IMG5825E270980429526.jpg, createdBy=f49f1974260, createdName=我是林下之夕, createdTime=Sun Dec 18 22:32:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163011, encodeId=549f163011d7, content=字习了学习再次学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 11:22:42 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162973, encodeId=74f81629e30d, content=跟进新进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Thu Dec 15 08:59:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162966, encodeId=b97c16296659, content=不错学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 08:50:26 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162954, encodeId=82dc1629545a, content=思路很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19061994286, createdName=1e1b1150m51(暂无匿称), createdTime=Thu Dec 15 08:18:31 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162864, encodeId=abe816286406, content=挺好的,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Wed Dec 14 23:08:37 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2017-01-20 wangjian123

    获益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1800436, encodeId=fc6c180043690, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Jun 14 22:11:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171533, encodeId=b9ca1e153371, content=获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0HwU7ogMvvRprWicAKSvxWXjwtmeo8SyGdWKEInVUiad7A5yiaAiaBue3SiaFNp57wAibKBCcvXrof9ZUV8fgV2jyNtw/0, createdBy=a2b42012587, createdName=wangjian123, createdTime=Fri Jan 20 09:41:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164661, encodeId=119116466127, content=感想,敢做,才能成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuIJQYq83p8jw8cQBJm4ya1HUMWB7ooS7HMvcNpiarQlbkDejrUObqFvEW3xb4xJvrfyVw0WR4ibBdh/0, createdBy=32fd1961793, createdName=399, createdTime=Wed Dec 21 16:09:45 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163994, encodeId=31f4163994e5, content=再次学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Dec 19 07:42:49 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163903, encodeId=3de316390347, content=高大上的研究啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161111/IMG5825E270980429526.jpg, createdBy=f49f1974260, createdName=我是林下之夕, createdTime=Sun Dec 18 22:32:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163011, encodeId=549f163011d7, content=字习了学习再次学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 11:22:42 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162973, encodeId=74f81629e30d, content=跟进新进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Thu Dec 15 08:59:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162966, encodeId=b97c16296659, content=不错学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 08:50:26 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162954, encodeId=82dc1629545a, content=思路很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19061994286, createdName=1e1b1150m51(暂无匿称), createdTime=Thu Dec 15 08:18:31 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162864, encodeId=abe816286406, content=挺好的,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Wed Dec 14 23:08:37 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2016-12-21 399

    感想,敢做,才能成功

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1800436, encodeId=fc6c180043690, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Jun 14 22:11:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171533, encodeId=b9ca1e153371, content=获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0HwU7ogMvvRprWicAKSvxWXjwtmeo8SyGdWKEInVUiad7A5yiaAiaBue3SiaFNp57wAibKBCcvXrof9ZUV8fgV2jyNtw/0, createdBy=a2b42012587, createdName=wangjian123, createdTime=Fri Jan 20 09:41:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164661, encodeId=119116466127, content=感想,敢做,才能成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuIJQYq83p8jw8cQBJm4ya1HUMWB7ooS7HMvcNpiarQlbkDejrUObqFvEW3xb4xJvrfyVw0WR4ibBdh/0, createdBy=32fd1961793, createdName=399, createdTime=Wed Dec 21 16:09:45 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163994, encodeId=31f4163994e5, content=再次学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Dec 19 07:42:49 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163903, encodeId=3de316390347, content=高大上的研究啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161111/IMG5825E270980429526.jpg, createdBy=f49f1974260, createdName=我是林下之夕, createdTime=Sun Dec 18 22:32:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163011, encodeId=549f163011d7, content=字习了学习再次学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 11:22:42 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162973, encodeId=74f81629e30d, content=跟进新进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Thu Dec 15 08:59:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162966, encodeId=b97c16296659, content=不错学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 08:50:26 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162954, encodeId=82dc1629545a, content=思路很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19061994286, createdName=1e1b1150m51(暂无匿称), createdTime=Thu Dec 15 08:18:31 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162864, encodeId=abe816286406, content=挺好的,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Wed Dec 14 23:08:37 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2016-12-19 大爰

    再次学习并分享感谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1800436, encodeId=fc6c180043690, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Jun 14 22:11:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171533, encodeId=b9ca1e153371, content=获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0HwU7ogMvvRprWicAKSvxWXjwtmeo8SyGdWKEInVUiad7A5yiaAiaBue3SiaFNp57wAibKBCcvXrof9ZUV8fgV2jyNtw/0, createdBy=a2b42012587, createdName=wangjian123, createdTime=Fri Jan 20 09:41:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164661, encodeId=119116466127, content=感想,敢做,才能成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuIJQYq83p8jw8cQBJm4ya1HUMWB7ooS7HMvcNpiarQlbkDejrUObqFvEW3xb4xJvrfyVw0WR4ibBdh/0, createdBy=32fd1961793, createdName=399, createdTime=Wed Dec 21 16:09:45 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163994, encodeId=31f4163994e5, content=再次学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Dec 19 07:42:49 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163903, encodeId=3de316390347, content=高大上的研究啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161111/IMG5825E270980429526.jpg, createdBy=f49f1974260, createdName=我是林下之夕, createdTime=Sun Dec 18 22:32:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163011, encodeId=549f163011d7, content=字习了学习再次学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 11:22:42 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162973, encodeId=74f81629e30d, content=跟进新进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Thu Dec 15 08:59:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162966, encodeId=b97c16296659, content=不错学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 08:50:26 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162954, encodeId=82dc1629545a, content=思路很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19061994286, createdName=1e1b1150m51(暂无匿称), createdTime=Thu Dec 15 08:18:31 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162864, encodeId=abe816286406, content=挺好的,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Wed Dec 14 23:08:37 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2016-12-18 我是林下之夕

    高大上的研究啊

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1800436, encodeId=fc6c180043690, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Jun 14 22:11:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171533, encodeId=b9ca1e153371, content=获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0HwU7ogMvvRprWicAKSvxWXjwtmeo8SyGdWKEInVUiad7A5yiaAiaBue3SiaFNp57wAibKBCcvXrof9ZUV8fgV2jyNtw/0, createdBy=a2b42012587, createdName=wangjian123, createdTime=Fri Jan 20 09:41:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164661, encodeId=119116466127, content=感想,敢做,才能成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuIJQYq83p8jw8cQBJm4ya1HUMWB7ooS7HMvcNpiarQlbkDejrUObqFvEW3xb4xJvrfyVw0WR4ibBdh/0, createdBy=32fd1961793, createdName=399, createdTime=Wed Dec 21 16:09:45 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163994, encodeId=31f4163994e5, content=再次学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Dec 19 07:42:49 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163903, encodeId=3de316390347, content=高大上的研究啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161111/IMG5825E270980429526.jpg, createdBy=f49f1974260, createdName=我是林下之夕, createdTime=Sun Dec 18 22:32:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163011, encodeId=549f163011d7, content=字习了学习再次学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 11:22:42 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162973, encodeId=74f81629e30d, content=跟进新进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Thu Dec 15 08:59:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162966, encodeId=b97c16296659, content=不错学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 08:50:26 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162954, encodeId=82dc1629545a, content=思路很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19061994286, createdName=1e1b1150m51(暂无匿称), createdTime=Thu Dec 15 08:18:31 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162864, encodeId=abe816286406, content=挺好的,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Wed Dec 14 23:08:37 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2016-12-15 大爰

    字习了学习再次学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1800436, encodeId=fc6c180043690, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Jun 14 22:11:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171533, encodeId=b9ca1e153371, content=获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0HwU7ogMvvRprWicAKSvxWXjwtmeo8SyGdWKEInVUiad7A5yiaAiaBue3SiaFNp57wAibKBCcvXrof9ZUV8fgV2jyNtw/0, createdBy=a2b42012587, createdName=wangjian123, createdTime=Fri Jan 20 09:41:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164661, encodeId=119116466127, content=感想,敢做,才能成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuIJQYq83p8jw8cQBJm4ya1HUMWB7ooS7HMvcNpiarQlbkDejrUObqFvEW3xb4xJvrfyVw0WR4ibBdh/0, createdBy=32fd1961793, createdName=399, createdTime=Wed Dec 21 16:09:45 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163994, encodeId=31f4163994e5, content=再次学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Dec 19 07:42:49 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163903, encodeId=3de316390347, content=高大上的研究啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161111/IMG5825E270980429526.jpg, createdBy=f49f1974260, createdName=我是林下之夕, createdTime=Sun Dec 18 22:32:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163011, encodeId=549f163011d7, content=字习了学习再次学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 11:22:42 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162973, encodeId=74f81629e30d, content=跟进新进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Thu Dec 15 08:59:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162966, encodeId=b97c16296659, content=不错学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 08:50:26 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162954, encodeId=82dc1629545a, content=思路很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19061994286, createdName=1e1b1150m51(暂无匿称), createdTime=Thu Dec 15 08:18:31 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162864, encodeId=abe816286406, content=挺好的,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Wed Dec 14 23:08:37 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2016-12-15 yafeiliutjh

    跟进新进展

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1800436, encodeId=fc6c180043690, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Jun 14 22:11:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171533, encodeId=b9ca1e153371, content=获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0HwU7ogMvvRprWicAKSvxWXjwtmeo8SyGdWKEInVUiad7A5yiaAiaBue3SiaFNp57wAibKBCcvXrof9ZUV8fgV2jyNtw/0, createdBy=a2b42012587, createdName=wangjian123, createdTime=Fri Jan 20 09:41:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164661, encodeId=119116466127, content=感想,敢做,才能成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuIJQYq83p8jw8cQBJm4ya1HUMWB7ooS7HMvcNpiarQlbkDejrUObqFvEW3xb4xJvrfyVw0WR4ibBdh/0, createdBy=32fd1961793, createdName=399, createdTime=Wed Dec 21 16:09:45 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163994, encodeId=31f4163994e5, content=再次学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Dec 19 07:42:49 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163903, encodeId=3de316390347, content=高大上的研究啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161111/IMG5825E270980429526.jpg, createdBy=f49f1974260, createdName=我是林下之夕, createdTime=Sun Dec 18 22:32:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163011, encodeId=549f163011d7, content=字习了学习再次学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 11:22:42 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162973, encodeId=74f81629e30d, content=跟进新进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Thu Dec 15 08:59:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162966, encodeId=b97c16296659, content=不错学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 08:50:26 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162954, encodeId=82dc1629545a, content=思路很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19061994286, createdName=1e1b1150m51(暂无匿称), createdTime=Thu Dec 15 08:18:31 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162864, encodeId=abe816286406, content=挺好的,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Wed Dec 14 23:08:37 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2016-12-15 大爰

    不错学习并分享感谢

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1800436, encodeId=fc6c180043690, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Jun 14 22:11:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171533, encodeId=b9ca1e153371, content=获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0HwU7ogMvvRprWicAKSvxWXjwtmeo8SyGdWKEInVUiad7A5yiaAiaBue3SiaFNp57wAibKBCcvXrof9ZUV8fgV2jyNtw/0, createdBy=a2b42012587, createdName=wangjian123, createdTime=Fri Jan 20 09:41:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164661, encodeId=119116466127, content=感想,敢做,才能成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuIJQYq83p8jw8cQBJm4ya1HUMWB7ooS7HMvcNpiarQlbkDejrUObqFvEW3xb4xJvrfyVw0WR4ibBdh/0, createdBy=32fd1961793, createdName=399, createdTime=Wed Dec 21 16:09:45 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163994, encodeId=31f4163994e5, content=再次学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Dec 19 07:42:49 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163903, encodeId=3de316390347, content=高大上的研究啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161111/IMG5825E270980429526.jpg, createdBy=f49f1974260, createdName=我是林下之夕, createdTime=Sun Dec 18 22:32:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163011, encodeId=549f163011d7, content=字习了学习再次学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 11:22:42 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162973, encodeId=74f81629e30d, content=跟进新进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Thu Dec 15 08:59:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162966, encodeId=b97c16296659, content=不错学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 08:50:26 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162954, encodeId=82dc1629545a, content=思路很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19061994286, createdName=1e1b1150m51(暂无匿称), createdTime=Thu Dec 15 08:18:31 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162864, encodeId=abe816286406, content=挺好的,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Wed Dec 14 23:08:37 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2016-12-15 1e1b1150m51(暂无匿称)

    思路很好

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1800436, encodeId=fc6c180043690, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Jun 14 22:11:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171533, encodeId=b9ca1e153371, content=获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0HwU7ogMvvRprWicAKSvxWXjwtmeo8SyGdWKEInVUiad7A5yiaAiaBue3SiaFNp57wAibKBCcvXrof9ZUV8fgV2jyNtw/0, createdBy=a2b42012587, createdName=wangjian123, createdTime=Fri Jan 20 09:41:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164661, encodeId=119116466127, content=感想,敢做,才能成功, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuIJQYq83p8jw8cQBJm4ya1HUMWB7ooS7HMvcNpiarQlbkDejrUObqFvEW3xb4xJvrfyVw0WR4ibBdh/0, createdBy=32fd1961793, createdName=399, createdTime=Wed Dec 21 16:09:45 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163994, encodeId=31f4163994e5, content=再次学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Dec 19 07:42:49 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163903, encodeId=3de316390347, content=高大上的研究啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161111/IMG5825E270980429526.jpg, createdBy=f49f1974260, createdName=我是林下之夕, createdTime=Sun Dec 18 22:32:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163011, encodeId=549f163011d7, content=字习了学习再次学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 11:22:42 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162973, encodeId=74f81629e30d, content=跟进新进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Thu Dec 15 08:59:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162966, encodeId=b97c16296659, content=不错学习并分享感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Dec 15 08:50:26 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162954, encodeId=82dc1629545a, content=思路很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19061994286, createdName=1e1b1150m51(暂无匿称), createdTime=Thu Dec 15 08:18:31 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162864, encodeId=abe816286406, content=挺好的,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Wed Dec 14 23:08:37 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2016-12-14 susice

    挺好的,学习了

    0

相关资讯

JAMA Cardiol:非糖尿病人群中,低随机血糖与心血管疾病低风险相关

非糖尿病人群中,低随机血糖与心血管疾病低风险相关

糖尿病周围神经病变,如何自我筛查?

糖尿病患者合并下肢周围神经病变,分为无痛性神经病变和痛性周围神经病变,这两种情况都会给患者的生活带来巨大的影响。前者因为患者的保护性感觉如痛觉、触觉、位置觉等丧失,因不易察觉小的足部皮肤损伤而导致溃疡出现、加重最后甚至需要截肢。而后者会因为给患者带来剧烈的疼痛如针刺痛、烧灼痛、刀割痛、触电样或钝痛等,给患者的生活和工作造成严重困扰,甚至会导致情绪、心理异常。所以,糖尿病周围神经病变的早期筛查、早期

四种糖尿病相关性昏迷的救治,性命攸关!

昏迷是糖尿病最主要的急性并发症之一,对患者的神经系统影响尤大,如果抢救不及时、昏迷时间持续6小时以上,就会造成脑组织不可逆的损伤,甚至死亡。导致糖尿病患者昏迷的原因有很多,大致可分为“糖尿病相关性昏迷”(如低血糖昏迷、酮症酸中毒昏迷、高渗性昏迷、乳酸性酸中毒昏迷等)和由合并症引起的昏迷(如急性脑卒中等)。本文主要谈谈“糖尿病相关性昏迷”的几种常见类型及救治要点。一、低血糖昏迷  当血糖低

Science子刊:糖尿病治疗新药可延缓帕金森病进展 明年将开始临床试验

一种处于临床申请阶段本来用于治疗糖尿病的新药将要用于一项帕金森病临床治疗研究,相关研究结果发表在国际学术期刊Science Translational Medicine上。到现在为止帕金森病治疗主要集中在对症状的控制。如果在人类临床试验中取得成功,MSDC-0160将成为世界上从根本上治疗这种疾病延缓疾病进展的首个治疗药物,或可实现对病人生活质量的改善,阻止认知能力下降的发生。还可以减少或推迟对药

细胞疗法有望让糖尿病患者告别胰岛素注射

近日,加州大学Irvine分校的研究人员开发了一种全新的细胞疗法。它有望能一劳永逸地治疗I型糖尿病患者,让他们免除每日注射胰岛素的烦恼。I型糖尿病又称胰岛素依赖型糖尿病,患者无法产生足够的胰岛素来调节体内血糖水平。I型糖尿病大约占糖尿病总数的10%左右,在中国每年每10万人中大约有1例新病例。尽管发病人数较少,但一旦发病后,患者便需要每天注射胰岛素以控制病情和维持生命。由于I型糖尿病往往在青少年时

2016年糖尿病重要研究进展回顾

2016年糖尿病重要研究进展回顾目前我国已成为全球糖尿病患者人数最多的国家。据最新数据显示,中国糖尿病患者人数已达1.14亿,约占全球糖尿病人总数的三分之一。降低血糖并不是糖尿病治疗的唯一目的,在有效控制血糖的同时,预防和减少低血糖风险或诱发的心血管事件等并发症,改善患者生活质量,延长患者生命才是最终目标。近年来关于糖尿病致病机理、新型疗法及药物、以及同其它疾病关联性的研究越来越多,层出不穷,

Baidu
map
Baidu
map
Baidu
map